Cagrilintide Overdose: Is it Possible?

Cagrilintide is a long‑acting amylin analogue (not a GIP/GLP‑1 receptor agonist) that is being studied both alone and in fixed‑dose combination with the GLP‑1 agonist semaglutide—a pairing known as CagriSema—for obesity and type 2 diabetes. In the phase 3 REDEFINE…
























